InsiderTrades.com logo

TPST Insider Trading

Insider Ownership Percentage: 4.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Tempest Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Tempest Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tempest Therapeutics Share Price & Price History

Current Price: $3.42
Price Change: ▲ Price Increase of +0.15 (4.59%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for TPST up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Tempest Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/12/2024Versant Venture Capital Vi, L.Major ShareholderSell29,846$14.30$426,797.8016,149View SEC Filing Icon  
8/8/2024Versant Venture Capital Vi, L.Major ShareholderSell30,769$17.55$539,995.9545,995View SEC Filing Icon  
7/3/2024Stephen R BradyCEOBuy2,692$27.43$73,841.563,567View SEC Filing Icon  
7/2/2024Samuel WhitingInsiderBuy359$27.69$9,940.71736View SEC Filing Icon  
6/28/2024Justin TrojanowskiInsiderBuy576$28.08$16,174.081,705View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Tempest Therapeutics (NASDAQ:TPST)

22.52% of Tempest Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TPST by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tempest Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/7/2025Vanguard Group Inc.162,560$1.67M0.0%+20.8%3.661%Search for SEC Filing on Google Icon
8/11/2025Versant Venture Management LLC269,772$1.83M2.2%-92.3%7.331%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC34,736$0.24M0.0%-92.0%0.944%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC189,506$0.16M0.0%N/A0.434%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC493,094$0.41M0.0%N/A1.130%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp67,815$57K0.0%+233.2%0.155%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd160,807$0.13M0.0%+570.3%0.368%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC354,276$0.30M0.0%+61.0%0.812%Search for SEC Filing on Google Icon
2/12/2025Versant Venture Management LLC3,507,055$2.93M3.4%N/A8.036%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC43,105$36K0.0%N/A0.099%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC220,067$0.31M0.0%+42.7%0.873%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd23,989$34K0.0%N/A0.095%Search for SEC Filing on Google Icon
11/5/2024Empower Advisory Group LLC35,000$49K0.0%N/A0.139%Search for SEC Filing on Google Icon
10/29/2024Fullcircle Wealth LLC62,000$87K0.0%N/A0.279%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC28,574$0.11M0.0%+69.2%0.129%Search for SEC Filing on Google Icon
2/15/2024MayTech Global Investments LLC10,000$44K0.0%N/A0.052%Search for SEC Filing on Google Icon
8/14/2023Rock Springs Capital Management LP536,214$0.68M0.0%-34.9%4.026%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.219,394$0.28M0.0%N/A1.893%Search for SEC Filing on Google Icon
2/14/2022Maven Securities LTD77,377$0.41M0.0%-39.0%1.120%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.15,240$0.22M0.0%N/A0.227%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC34,104$0.49M0.0%+26.9%0.509%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.82,698$1.20M0.0%+1,581.2%1.234%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC60,000$0.87M0.2%-47.2%0.896%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tempest Therapeutics logo
Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Read More on Tempest Therapeutics

Today's Range

Now: $3.42
Low: $3.25
High: $3.48

50 Day Range

MA: $8.62
Low: $3.03
High: $11.83

52 Week Range

Now: $3.42
Low: $3.00
High: $13.65

Volume

245,337 shs

Average Volume

220,257 shs

Market Capitalization

$15.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Tempest Therapeutics?

Tempest Therapeutics' top insider investors include:
  1. Versant Venture Capital Vi, L (Major Shareholder)
  2. Stephen R Brady (CEO)
  3. Justin Trojanowski (Insider)
  4. Samuel Whiting (Insider)
Learn More about top insider investors at Tempest Therapeutics.

Who are the major institutional investors of Tempest Therapeutics?

Tempest Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 3.66%
  2. Belvedere Trading LLC — 0.00%
  3. Susquehanna International Group LLP — 0.00%
  4. Group One Trading LLC — 0.00%
Learn More about top institutional investors of Tempest Therapeutics stock.

Which institutional investors are selling Tempest Therapeutics stock?

Within the last quarter, TPST stock was sold by these institutional investors:
  1. Susquehanna International Group LLP
  2. Group One Trading LLC

Which institutional investors are buying Tempest Therapeutics stock?

During the last quarter, TPST stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. Belvedere Trading LLC
Within the previous year, these company insiders have bought Tempest Therapeutics stock:
  1. Versant Venture Capital Vi, L (Major Shareholder)
  2. Stephen R Brady (CEO)
  3. Justin Trojanowski (Insider)
Learn More investors buying Tempest Therapeutics stock.